Company: PTHS
Filing Date: 2025-05-09
Form Type: PREM14C
Source: 0001140361-25-018219
Chunk: 783

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-09
Form: PREM14C
Chunk 783
---
VED , that the Authorized Officer be, and he acting singly hereby is, authorized and empowered, in the name and on behalf of the Company and the Consenting Stockholders, to file a draft preliminary information statement prepared in accordance with Section 14(c) and Schedule 14C of the Exchange Act (such information statement, including in definitive form, the “ Information Statement ”) and/or a Registration Statement on Form S-4, as applicable (the “ Form S-4 ”, and together with the Information Statement, the “ Information Statement/Form S-4 ”), with such changes thereto as may be necessary or desirable to respond to comments thereon from the SEC, and with such other nonmaterial changes, or such other conforming or updating changes, thereto as may hereafter be determined to be appropriate by the Authorized Officer, including, without limitation, to put such Information Statement/Form S-4 in definitive form, and that the Authorized Person be, and he hereby is, authorized and empowered, in the name and on behalf of the Company, to cause the same to be filed (including in definitive form) with the SEC, as required or determined by such Authorized Officer to be appropriate, which determinations and the Board’s ratification and approval thereof shall be conclusively evidenced by the authorization of the filing or transmitting thereof with or to the SEC by such Authorized Officer; and be it further

RESOLVED , that the Authorized Officer be, and he acting singly hereby is, authorized and empowered, in the name and on behalf of the Company, to execute and file or cause to be executed and filed all such other reports, statements, documents and information required to be filed by the Company pursuant to the Exchange Act and the rules and regulations promulgated thereunder, in connection with the Information Statement and to transmit the same to each Company Stockholder as may be required by applicable law; and be it further

#### Camden Note Conversion
RESOLVED , that the Camden Note Conversion in connection with the Financing and the other transactions contemplated by the Financing Documents be, and hereby is, authorized, adopted and approved in all respects; and be it further

#### Ratification of Prior Actions
RESOLVED , that all prior actions, transactions, agreements, certificates or other documents previously signed, submitted or filed in connection with foregoing, including, without limitation, the Company’s entry into the Letter

<div align='center'>E-6</div>

#### TABLE OF CONTENTS
Agreement with Ligand and Nomis Bay, dated as